News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Carmen Uscatu: Efficiency means quality
Carmen Uscatu/LinkedIn
Sep 26, 2024, 18:13

Carmen Uscatu: Efficiency means quality

Carmen Uscatu, Founding Member and President of Give Life, shared a post on LinkedIn:

“Efficiency means quality. Learn about what the Dăruiește Viață initiative for pediatric oncology in Romania means from the article by Ziarul Financiar.”

Carmen Uscatu: Efficiency means quality

Source: Carmen Uscatu/LinkedIn

More posts featuring Carmen Uscatu on oncodaily.com

cancer Carmen Uscatu Dăruiește Viață Give Life OncoDaily Oncology Ziarul Financiar
Special Coverage
Blog
Aug 8, 2025, 13:46
Diane Bodurka: The Caliber of the Research at MD Anderson Cancer Center
Blog
Aug 8, 2025, 13:45
Applications are Open For Cervical Screening Integration Grants - Cancer Institute NSW
Career
Aug 8, 2025, 13:40
SITC Welcomes Julie R. Brahmer to the 2025 Class of the Academy of Immuno-Oncology
Blog
Aug 8, 2025, 13:38
Chadi Nabhan: Sumanta Pal⁩ Joins HUExpress to Simplify Approach to Papillary Renal Cell Cancer
Science
Aug 8, 2025, 13:26
Kamlesh Khunti: GLP-1 and SGLT2 in T2D - Discontinuation, Reinitiation and Switching Swedish registry data
Blog
Aug 8, 2025, 13:14
Claudia Villa Celi: The Other Side of Fellowship
Career
Aug 8, 2025, 13:14
Nicholas Navin: The Future of Cancer Research
Science
Aug 8, 2025, 13:11
Scott Kopetz: A Promising Strategy for KRASi Resistance
Blog
Aug 8, 2025, 13:00
Matt Dun: The First Therapeutic Step Forward for H3K27-Altered Diffuse Midline Glioma
Blog
Aug 8, 2025, 13:00
Sumanta K. Pal Supports Petros Grivas' "Obliteride" Campaign to Cure Bladder Cancer
Science
Aug 8, 2025, 12:39
Yan Leyfman: Analyzing Demographic Trends in NCI-Sponsored Early-Phase Cancer Clinical Trials
Insight
Aug 8, 2025, 12:19
Yazan Madanat Presented KOMET-007 Results at the 4th Translational Summit on Heme Malignancies